EUVIMEDEUVIMED entdecken
Crossref

Intratracheal Delivery of mRNA Lipid Nanoparticles Reprograms Alveolar Macrophages for Pulmonary Cancer Immunotherapy

Jiayi Zhou, Tanzhuoyi Li, Weiwei Zhang, Panshuang Qiao, Huiyu Zhang, Zihan Ding, Yilei Lu, Jiongran Yu, Jing Ding, Hang Chen, Dezhong Ji, Yiguang Wang iD und 1 weitere

ACS Nano · 11.08.2026 · 20 (31) · 21798-21811

DOI: 10.1021/acsnano.6c04529 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACS Nano, online erschienen am 31.07.2026. Verfasst von Jiayi Zhou und 12 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences, Peking University, Beijing100191, China. Hauptthemen laut MEDLINE: Macrophages, Alveolar, Lung Neoplasms, Nanoparticles, Immunotherapy. Die Arbeit nennt 39 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Ministry of Education of the People's Republic of China, China Postdoctoral Science Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Pulmonary delivery of lipid nanoparticle (LNP)-based mRNA vaccines offers a promising strategy for localized lung cancer immunotherapy, yet how distinct pulmonary administration routes determine cellular targeting and therapeutic efficacy remains poorly understood. Here, we systematically evaluate intranasal and intratracheal delivery of mRNA-LNP vaccines and reveal a route-dependent immunological mechanism governing lung-targeted tumor vaccination. Although intratracheal administration yields only a 2.6-fold increase in total pulmonary protein expression compared to intranasal delivery, it produces a striking 26.8-fold enhancement in functional mRNA transfection efficiency within alveolar macrophages, the dominant antigen-presenting cell population in the alveolar space. This selective targeting reprograms alveolar macrophages toward an activated antigen-presenting phenotype, promoting efficient antigen presentation, robust CD8+ T-cell responses, and superior prophylactic and therapeutic efficacy in pulmonary tumor models. Notably, local depletion of alveolar macrophages completely abolishes the antitumor protection conferred by intratracheal vaccination, establishing their indispensable role in mediating pulmonary mRNA vaccine efficacy. Together, these findings provide mechanistic insights into lung-targeted mRNA cancer vaccination driven by alveolar macrophage engagement, providing critical insights for the design of next-generation LNP-based nanomedicines for lung cancer immunotherapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Macrophages, AlveolarLung NeoplasmsNanoparticlesImmunotherapyRNA, MessengerLipidsCancer VaccinesAnimalsMiceMice, Inbred C57BLFemaleHumansLiposomes

Stichwörter der Autor:innen

alveolar macrophagecancer immunotherapylipid nanoparticle (LNP)mRNA vaccinespulmonary delivery

Substanzen

RNA, MessengerLipidsCancer VaccinesLipid NanoparticlesLiposomes

Autor:innen und Institutionen

  • State Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences, Peking University, Beijing100191, China.
  • Beijing Key Laboratory of Advanced Pharmaceutical Preparation, School of Pharmaceutical Sciences, Peking University, Beijing100191, China.
  • Department of Pediatrics, Peking University People's Hospital, Beijing100044, China.
  • Chemical Biology Center, Peking University, Beijing100191, China.
  • Ningbo Institute of Marine Medicine, Peking University, Ningbo315832, China.

ORCID-Profile: Yiguang Wang, Binlong Chen

Förderung

  • National Natural Science Foundation of China
  • Ministry of Education of the People's Republic of China
  • China Postdoctoral Science Foundation
  • Natural Science Foundation of Beijing Municipality
  • Beijing Nova Program
  • Peking University Medicine plus X Pilot Program-Key Technologies Research and Development Project

Zitieren

APA

Zhou, J., Li, T., Zhang, W., Qiao, P., Zhang, H., Ding, Z., Lu, Y., Yu, J., Ding, J., Chen, H., Ji, D., Wang, Y., & Chen, B. (2026). Intratracheal Delivery of mRNA Lipid Nanoparticles Reprograms Alveolar Macrophages for Pulmonary Cancer Immunotherapy. ACS Nano, 20(31), 21798-21811. https://doi.org/10.1021/acsnano.6c04529

Vancouver

Zhou J, Li T, Zhang W, Qiao P, Zhang H, Ding Z, et al. Intratracheal Delivery of mRNA Lipid Nanoparticles Reprograms Alveolar Macrophages for Pulmonary Cancer Immunotherapy. ACS Nano. 2026;20(31):21798-21811. doi:10.1021/acsnano.6c04529

BibTeX
@article{Zhou2026,
  author = {Zhou, Jiayi and Li, Tanzhuoyi and Zhang, Weiwei and Qiao, Panshuang and Zhang, Huiyu and Ding, Zihan and Lu, Yilei and Yu, Jiongran and Ding, Jing and Chen, Hang and Ji, Dezhong and Wang, Yiguang and Chen, Binlong},
  title = {Intratracheal Delivery of mRNA Lipid Nanoparticles Reprograms Alveolar Macrophages for Pulmonary Cancer Immunotherapy},
  journal = {ACS Nano},
  year = {2026},
  volume = {20},
  number = {31},
  pages = {21798--21811},
  doi = {10.1021/acsnano.6c04529}
}
Kostenlos starten →